Ketogenic Diet and Diabetes Demonstration Project
Part of paid clinical trials in Albuquerque, New Mexico.
- Sponsor
- University of New Mexico
- Study ID
- NCT06115265
- Status
- Recruiting
Conditions
- Ketogenic Dieting
- Obesity
- PreDiabetes
- Type 2 Diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Ketogenic diet — BEHAVIORALKDDP and NDPP will deliver identical comprehensive lifestyle counseling and follow up to participants, but dietary interventions in each group will differ, with KDDP participants receiving a ketogenic diet and NDPP participants receiving a low fat diet.
- Low Fat diet — BEHAVIORALKDDP and NDPP will deliver identical comprehensive lifestyle counseling and follow up to participants, but dietary interventions in each group will differ, with KDDP participants receiving a ketogenic diet and NDPP participants receiving a low fat diet.
Study Details
KDDP is a prospective, 12-month pilot study comparing the effects of a novel lifestyle program, the Ketogenic Diet and Diabetes Demonstration Project (KDDP) to those of the National Diabetes Prevention Program (NDDP). KDDP is modeled to mimic the delivery platform of NDPP with the exception that participants in KDDP will be placed on a medically-supervised ketogenic diet, and participants in NDPP will be placed on a low fat diet. The purpose of this study is to compare the metabolic effects of the KDDP and the NDPP on glycemic control, lipid parameters, blood pressure, heart rate, weight, and coronary artery calcium scores in individuals with either type 2 diabetes or prediabetes.
Key Dates
- Start date
- Sep 5, 2023
- Status verified
- Jun 2025
- Primary completion
- May 30, 2026
- Completion
- Oct 1, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: KDDPKDDP - Participants enrolled in the KDDP arm will be placed on a traditional ketogenic diet (\<20 grams of carbohydrate/day).
- Experimental: NDPPNDPP - Participants enrolled in the NDPP arm will be placed on a low fat diet.
Primary Outcome Measure
Weight in kg [ Time Frame: 12 months ]
Central Contacts
- Kristen M Gonzales, MD505-272-3840
- Matthew Bouchonville, MD505-272-3840
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of New Mexico | Albuquerque | New Mexico | 87131 |
Find similar trials in Albuquerque, NM
Related Studies
- The Diabetes Prevention Program Outcomes Study AD/ADRD ProjectEnrolling By Invitation · Marinella Temprosa · Phoenix, Arizona
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)PHASE3 · Recruiting · Eli Lilly and Company · Tucson, Arizona
- Effect of Tirzepatide on Markers of MASLD in Patients With ObesityEARLY_PHASE1 · Recruiting · University of New Mexico · Albuquerque, New Mexico
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesPHASE3 · Recruiting · Eli Lilly and Company · Birmingham, Alabama